Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1021-2018

Drug recall · August 8, 2018

Valsartan/HCTZ 320mg/12.5 mg tablet recall

Why: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Valsartan/HCTZ 320mg/12.5 mg tablet, 90-count bottle, Rx only, RemedyRepack, 625 Kolter Drive, Suite 4, Indiana, PA 15701

Lots / codes

Lot # B0383153-122917; Exp. 12/18

Quantity
3 HDPE 90-count bottles (270 tablets)
Company
RemedyRepack Inc., Indiana, PA
Distribution
Product was distributed to 3 medical facilities in Florida.
Initiated
July 17, 2018 · Voluntary: Firm initiated
Classified
July 31, 2018
Reported
August 8, 2018
Ended
October 17, 2018
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Valsartan

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.